Shares of Zoetis Inc. (NYSE:ZTS - Get Free Report) have earned a consensus rating of "Hold" from the twenty research firms that are currently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, eleven have assigned a hold recommendation and eight have assigned a buy recommendation to the company. The average 12 month price objective among analysts that have issued a report on the stock in the last year is $101.25.
A number of analysts have recently commented on the stock. Citigroup cut their price objective on shares of Zoetis from $112.00 to $96.00 and set a "buy" rating on the stock in a research report on Tuesday, August 11th. JPMorgan Chase & Co. reduced their target price on shares of Zoetis from $130.00 to $115.00 and set an "overweight" rating for the company in a report on Friday, August 7th. Cantor Fitzgerald set a $94.00 target price on shares of Zoetis in a research report on Tuesday, August 25th. Weiss Ratings upgraded shares of Zoetis from a "sell (d)" rating to a "sell (d+)" rating in a research note on Thursday, October 29th. Finally, Piper Sandler lowered their price target on shares of Zoetis from $90.00 to $80.00 and set a "neutral" rating on the stock in a research note on Monday, August 10th.
Check Out Our Latest Analysis on ZTS
Institutional Trading of Zoetis
A number of hedge funds and other institutional investors have recently modified their holdings of ZTS. BlackRock Inc. grew its holdings in Zoetis by 10.8% during the second quarter. BlackRock Inc. now owns 39,430,181 shares of the company's stock worth $2,833,453,000 after purchasing an additional 3,845,869 shares during the period. State Street Corp increased its position in Zoetis by 1.8% during the second quarter. State Street Corp now owns 19,667,723 shares of the company's stock worth $1,413,323,000 after buying an additional 343,322 shares during the last quarter. Bank of America Corp DE increased its position in Zoetis by 7.3% during the first quarter. Bank of America Corp DE now owns 4,831,652 shares of the company's stock worth $571,150,000 after buying an additional 327,313 shares during the last quarter. Deutsche Bank AG raised its stake in Zoetis by 5.8% in the second quarter. Deutsche Bank AG now owns 5,851,737 shares of the company's stock valued at $420,506,000 after buying an additional 319,709 shares during the period. Finally, Van ECK Associates Corp raised its stake in Zoetis by 7.7% in the second quarter. Van ECK Associates Corp now owns 4,252,140 shares of the company's stock valued at $305,559,000 after buying an additional 303,395 shares during the period. Institutional investors and hedge funds own 92.80% of the company's stock.
Zoetis Stock Down 5.5%
NYSE:ZTS opened at $80.85 on Friday. The company has a debt-to-equity ratio of 2.51, a quick ratio of 1.40 and a current ratio of 2.35. The company has a market cap of $32.85 billion, a PE ratio of 13.75, a PEG ratio of 1.24 and a beta of 0.67. Zoetis has a 52-week low of $68.77 and a 52-week high of $132.49. The stock has a 50-day simple moving average of $77.04 and a 200 day simple moving average of $90.76.
Zoetis (NYSE:ZTS - Get Free Report) last released its earnings results on Thursday, November 5th. The company reported $1.75 EPS for the quarter, beating the consensus estimate of $1.51 by $0.24. The firm had revenue of $2.39 billion for the quarter, compared to analysts' expectations of $2.30 billion. Zoetis had a return on equity of 85.90% and a net margin of 26.15%. The business's quarterly revenue was down 1.3% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.70 EPS. On average, sell-side analysts expect that Zoetis will post 6.29 EPS for the current fiscal year.
Zoetis Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 1st. Stockholders of record on Friday, October 30th will be issued a $0.53 dividend. The ex-dividend date is Friday, October 30th. This represents a $2.12 annualized dividend and a dividend yield of 2.6%. Zoetis's dividend payout ratio (DPR) is presently 36.05%.
Top Zoetis Stories
Investors following ZTS have been watching these stories:
Zoetis Company Profile
(
Get Free Report)
Zoetis is an animal health company that discovers, develops, manufactures and markets medicines, vaccines, diagnostic products and other services for animals. Its products support both companion animals, such as dogs and cats, and livestock, including cattle, pigs, poultry, sheep and fish. The company's offerings include treatments for pain, infections and skin conditions, as well as vaccines, parasiticides, diagnostic tools and genetic testing services. Zoetis serves veterinarians, livestock producers and other animal health professionals around the world.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Zoetis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zoetis wasn't on the list.
While Zoetis currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.